Kelly; Terence A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kelly; Terence A..The latest application filed is for "compositions and methods for inhibiting kinases".

Company Profile

4.8.7

Kelly; Terence A. - Ridgefield CT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions and methods for inhibiting kinases Grant 11,407,747 - Werner , et al. August 9, 2	2022-08-09
Compositions And Methods For Inhibiting Kinases App 20210130343 - Werner; Milton H. ; et al.	2021-05-06
Compositions and methods for inhibiting kinases Grant 10,906,896 - Werner , et al. February 2, 2	2021-02-02
Compositions And Methods For Inhibiting Kinases App 20200046699 - Werner; Milton H. ; et al.	2020-02-13
Compositions And Methods For Inhibiting Kinases App 20200031819 - Werner; Milton H. ; et al.	2020-01-30
Compositions and methods for inhibiting kinases Grant 10,344,027 - Werner , et al. July 9, 2	2019-07-09
Compositions and methods for inhibiting kinases Grant 10,316,031 - Werner , et al.	2019-06-11
Compositions And Methods For Inhibiting Kinases App 20190119266 - Werner; Milton H. ; et al.	2019-04-25
Compositions And Methods For Inhibiting Kinases App 20190055234 - WERNER; Milton H. ; et al.	2019-02-21
Compositions and methods for inhibiting kinases Grant 10,118,923 - Werner , et al. November 6, 2	2018-11-06
Compositions And Methods For Inhibiting Kinases App 20180057488 - Werner; Milton H. ; et al.	2018-03-01
Compositions and methods for inhibiting kinases Grant 9,828,370 - Werner , et al. November 28, 2	2017-11-28
Compositions And Methods For Inhibiting Kinases App 20160311816 - Werner; Milton H. ; et al.	2016-10-27
Derivatives of [6,7-dihydro-5H-imidazo[1,2--a]imidazole-3-sulfonyl]-pyrrolidine-2-carbox- ylic acid amide Grant 7,462,637 - Kelly , et al. December 9, 2	2008-12-09
Phenylpyrrolidines, phenylimidazolidines, 3-phenyl-1,3-oxizolidines and 3-phenyl-1,3-thiazolidines and their use in the treatment of inflammatory disease Grant 6,355,664 - Kelly , et al. March 12, 2	2002-03-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.